Home ETF List About

Portfolio Holdings Detail for ISIN IE00BFNM3G45
Stock Name / FundiShares MSCI USA ESG Screened UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerSASU(USD) LSE
ETF TickerGPSA(GBP) LSE
ETF TickerSGAS(EUR) F
ETF TickerGPSA.LS(GBP) CXE
ETF TickerSASU.LS(USD) CXE
ETF TickerSASUz(USD) CXE
ETF TickerSGAS.DE(EUR) CXE
ETF TickerSASU.L(GBP) LSE
ETF TickerGPSA.L(GBP) LSE

Holdings detail for BMRN

Stock NameBiomarin Pharmaceutical Inc
TickerBMRN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS09061G1013
LEINSLL8ITTRR0J5HEMR848

Show aggregate BMRN holdings

News associated with BMRN

BioMarin Pharmaceutical (NASDAQ:BMRN) Coverage Initiated at HC Wainwright
HC Wainwright assumed coverage on shares of BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) in a note issued to investors on Monday, MarketBeat.com reports. The firm set a “neutral” rating and a $60.00 price target on the biotechnology company’s stock. HC Wainwright’s price objective points to a potential upside of 7.74% from the stock’s previous […] - 2025-09-10 03:13:10
Predicting the Next Rule Breaker Buyout
In this Motley Fool Money podcast, Motley Fool analyst Karl Thiel and contributors Rick Munarriz and Jason Hall dig into four growth stocks ripe for the acquiring. There's also two sides to Tesla's changing AI story and a new kind of stock quote game. - 2025-08-19 01:08:00
9,709 Shares in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Bought by Atria Wealth Solutions Inc.
Atria Wealth Solutions Inc. bought a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 9,709 shares of the biotechnology company’s stock, valued at approximately $686,000. Several other hedge funds and other institutional investors also […] - 2025-08-13 04:49:08
Natixis Advisors LLC Grows Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Natixis Advisors LLC raised its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 68.3% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,226 shares of the biotechnology company’s stock after buying an additional 13,488 shares during the quarter. Natixis Advisors […] - 2025-08-08 07:20:44
Guggenheim Issues Positive Forecast for BioMarin Pharmaceutical (NASDAQ:BMRN) Stock Price
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report) had its target price hoisted by investment analysts at Guggenheim from $101.00 to $106.00 in a note issued to investors on Wednesday,Benzinga reports. The brokerage presently has a “buy” rating on the biotechnology company’s stock. Guggenheim’s price objective indicates a potential upside of 78.27% from the company’s current […] - 2025-08-08 04:26:58
BMRN Makes Bullish Cross Above Critical Moving Average
In trading on Tuesday, shares of BioMarin Pharmaceutical Inc (Symbol: BMRN) crossed above their 200 day moving average of $63.38, changing hands as high as $63.97 per share. BioMarin Pharmaceutical Inc shares are currently trading up about 5.7% on the day. The chart below show - 2025-08-05 12:47:37
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Receives $93.74 Average Target Price from Analysts
Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) have been assigned an average rating of “Moderate Buy” from the twenty-four research firms that are presently covering the company, Marketbeat Ratings reports. Six equities research analysts have rated the stock with a hold recommendation and eighteen have given a buy recommendation to the company. […] - 2025-08-05 02:55:15
Biomarin Pharmaceutical Q2 25 Earnings Conference Call At 4:30 PM ET
(RTTNews) - Biomarin Pharmaceutical Inc. (BMRN) will host a conference call at 4:30 PM ET on August 4, 2025, to discuss Q2 25 earnings results. - 2025-08-04 08:30:49
Signaturefd LLC Increases Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Signaturefd LLC boosted its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 19.1% during the 1st quarter, Holdings Channel reports. The institutional investor owned 2,191 shares of the biotechnology company’s stock after acquiring an additional 352 shares during the period. Signaturefd LLC’s holdings in BioMarin Pharmaceutical were worth $155,000 as of […] - 2025-07-21 05:36:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC lifted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.0% in the first quarter, Holdings Channel reports. The firm owned 4,572 shares of the biotechnology company’s stock after buying an additional 217 shares during the period. Nisa Investment Advisors LLC’s holdings in BioMarin Pharmaceutical were worth $323,000 as […] - 2025-07-17 06:25:00
Cerity Partners LLC Raises Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Cerity Partners LLC raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 203.7% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 84,832 shares of the biotechnology company’s stock after acquiring an additional 56,897 shares during the period. […] - 2025-07-17 05:51:03
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Raised to $113.00
BioMarin Pharmaceutical (NASDAQ:BMRN – Free Report) had its price objective upped by JPMorgan Chase & Co. from $108.00 to $113.00 in a research report sent to investors on Monday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the biotechnology company’s stock. Other equities analysts have also issued research reports about the […] - 2025-07-17 04:48:52
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Bought by Xponance Inc.
Xponance Inc. raised its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% during the 1st quarter, according to its most recent filing with the SEC. The firm owned 31,877 shares of the biotechnology company’s stock after buying an additional 202 shares during the quarter. Xponance Inc.’s holdings in BioMarin Pharmaceutical were worth […] - 2025-07-15 07:02:50
D.A. Davidson & CO. Has $480,000 Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
D.A. Davidson & CO. lessened its position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 9.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,788 shares of the biotechnology company’s stock after selling 746 shares during the quarter. D.A. Davidson […] - 2025-07-11 05:32:53
Brokerages Set BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) PT at $93.61
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the twenty-four ratings firms that are presently covering the firm, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating and eighteen have assigned a buy rating to the company. The average 1 […] - 2025-07-11 02:56:50
Principal Financial Group Inc. Boosts Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Principal Financial Group Inc. lifted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.3% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 455,485 shares of the biotechnology company’s stock after purchasing an additional 1,549 shares during […] - 2025-07-08 06:26:49
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Sumitomo Mitsui Trust Group Inc.
Sumitomo Mitsui Trust Group Inc. lowered its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 0.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 467,245 shares of the biotechnology company’s stock after selling 2,798 shares during the period. Sumitomo Mitsui Trust Group […] - 2025-07-03 06:13:02
Bessemer Group Inc. Has $327,000 Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Bessemer Group Inc. reduced its stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.9% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,618 shares of the biotechnology company’s stock after selling 683 shares during the quarter. Bessemer Group Inc.’s […] - 2025-07-03 05:00:50
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Purchased by Robeco Institutional Asset Management B.V.
Robeco Institutional Asset Management B.V. boosted its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 97,261 shares of the biotechnology company’s stock after purchasing an additional 10,687 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in BioMarin Pharmaceutical were […] - 2025-06-30 05:06:50
Kentucky Retirement Systems Insurance Trust Fund Acquires New Holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the first quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 5,490 shares of the biotechnology company’s stock, valued at approximately $388,000. A number of other institutional investors have also […] - 2025-06-26 05:04:54
Kentucky Retirement Systems Buys New Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Kentucky Retirement Systems bought a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, HoldingsChannel.com reports. The institutional investor bought 12,890 shares of the biotechnology company’s stock, valued at approximately $911,000. Other hedge funds have also recently added to or reduced their stakes in the company. Farther Finance […] - 2025-06-25 05:40:49
Exchange Traded Concepts LLC Acquires 979 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Exchange Traded Concepts LLC boosted its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 5.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 19,796 shares of the biotechnology company’s stock after acquiring an additional 979 shares during the quarter. Exchange Traded […] - 2025-06-19 04:58:54
Mn Services Vermogensbeheer B.V. Boosts Stock Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Mn Services Vermogensbeheer B.V. increased its stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 12.0% during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 35,500 shares of the biotechnology company’s stock after buying an additional 3,800 shares during the period. Mn Services Vermogensbeheer […] - 2025-06-18 05:44:54
NorthCrest Asset Manangement LLC Acquires Shares of 4,885 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
NorthCrest Asset Manangement LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 4,885 shares of the biotechnology company’s stock, valued at approximately $345,000. Other hedge funds and […] - 2025-06-16 05:36:54
UMB Bank n.a. Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
UMB Bank n.a. grew its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 120.5% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,247 shares of the biotechnology company’s stock after acquiring an additional 1,228 shares during the period. UMB Bank […] - 2025-06-12 05:32:57
Gateway Investment Advisers LLC Cuts Position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Gateway Investment Advisers LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 22.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,512 shares of the biotechnology company’s stock after selling 1,003 shares during the period. Gateway Investment Advisers LLC’s […] - 2025-06-10 05:26:59
Here Are All 6 Stocks I've Bought Through 5 Months of 2025
It's been a wild ride for the stock market through the first five months of 2025. As of mid-February, Wall Street's major stock indexes could do no wrong, with the benchmark S&P 500 vaulting to an all-time record-closing high. But over the next two months, tariff-related unce - 2025-06-05 04:06:00
Tidal Investments LLC Sells 17,428 Shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Tidal Investments LLC lessened its holdings in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) by 57.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 13,039 shares of the biotechnology company’s stock after selling 17,428 shares during the quarter. Tidal Investments LLC’s holdings in BioMarin […] - 2025-05-27 05:21:04
Quantinno Capital Management LP Purchases Shares of 5,848 BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)
Quantinno Capital Management LP bought a new position in shares of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 5,848 shares of the biotechnology company’s stock, valued at approximately $384,000. A number […] - 2025-05-26 04:58:58
Analysts See 10% Upside For The Holdings of ILCB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-19 07:58:34

iShares MSCI USA ESG Screened UCITS ETF USD (Acc) BMRN holdings

DateNumber of BMRN Shares HeldBase Market Value of BMRN SharesLocal Market Value of BMRN SharesChange in BMRN Shares HeldChange in BMRN Base ValueCurrent Price per BMRN Share HeldPrevious Price per BMRN Share Held
2025-09-29 (Monday)61,416USD 3,317,692USD 3,317,692
2025-09-26 (Friday)61,150USD 3,292,928USD 3,292,928
2025-09-25 (Thursday)60,554BMRN holding increased by 42USD 3,186,351BMRN holding decreased by -67379USD 3,186,35142USD -67,379 USD 52.62 USD 53.77
2025-09-24 (Wednesday)60,512USD 3,253,730USD 3,253,730
2025-09-18 (Thursday)59,707BMRN holding increased by 168USD 3,292,244BMRN holding increased by 55109USD 3,292,244168USD 55,109 USD 55.14 USD 54.37
2025-09-17 (Wednesday)59,539BMRN holding increased by 210USD 3,237,135BMRN holding increased by 36929USD 3,237,135210USD 36,929 USD 54.37 USD 53.94
2025-09-16 (Tuesday)59,329BMRN holding increased by 336USD 3,200,206BMRN holding increased by 65318USD 3,200,206336USD 65,318 USD 53.94 USD 53.14
2025-09-15 (Monday)58,993USD 3,134,888USD 3,134,888
2025-09-12 (Friday)58,881USD 3,184,873USD 3,184,873
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BMRN by Blackrock for IE00BFNM3G45

Show aggregate share trades of BMRN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-25BUY42 52.620* 62.98
2025-09-18BUY168 55.140* 63.02
2025-09-17BUY210 54.370* 63.07
2025-09-16BUY336 53.940* 63.12
2025-08-15BUY28 57.540* 63.18
2025-08-13BUY15 58.300* 63.21
2025-07-31BUY70 57.850* 63.27
2025-07-29BUY280 58.230* 63.33
2025-07-28BUY52 58.140* 63.36
2025-07-25BUY84 59.010* 63.38
2025-07-24BUY41 59.760* 63.40
2025-07-23BUY98 59.670* 63.43
2025-07-22BUY56 59.200* 63.45
2025-07-18BUY88 57.290* 63.53
2025-07-17BUY84 58.370* 63.56
2025-07-07SELL-84 57.410* 63.74 Profit of 5,354 on sale
2025-07-02SELL-367 57.170* 63.86 Profit of 23,435 on sale
2025-06-27BUY47 55.170* 63.97
2025-06-26BUY42 54.100* 64.03
2025-06-24SELL-196 54.690* 64.15 Profit of 12,574 on sale
2025-06-18BUY112 55.240* 64.40
2025-06-17BUY42 55.000* 64.46
2025-06-16SELL-57 56.240* 64.52 Profit of 3,677 on sale
2025-06-13BUY123 56.220* 64.57
2025-06-12SELL-70 57.280* 64.62 Profit of 4,524 on sale
2025-06-11BUY154 57.160* 64.67
2025-06-06BUY42 56.650* 64.84
2025-06-05BUY196 55.270* 64.90
2025-06-04BUY28 56.110* 64.96
2025-06-03SELL-14 56.790* 65.02 Profit of 910 on sale
2025-05-30SELL-1,708 58.070* 65.13 Profit of 111,245 on sale
2025-05-29BUY38 58.550* 65.18
2025-05-27BUY244 58.110* 65.28
2025-05-23BUY195 57.550* 65.40
2025-05-22BUY98 58.010* 65.46
2025-05-19BUY84 59.410* 65.60
2025-05-16BUY42 59.270* 65.65
2025-05-15SELL-28 58.270* 65.71 Profit of 1,840 on sale
2025-05-14BUY14 58.700* 65.76
2025-05-13BUY28 59.780* 65.81
2025-05-12BUY88 61.370* 65.85
2025-05-09SELL-70 58.860* 65.90 Profit of 4,613 on sale
2025-05-08BUY26 59.820* 65.95
2025-05-07BUY39 59.320* 66.01
2025-05-02BUY1,443 62.030* 66.13
2025-04-30BUY455 63.690* 66.18
2025-04-29BUY117 63.280* 66.21
2025-04-28BUY91 62.980* 66.23
2025-04-25BUY234 63.300* 66.26
2025-04-24SELL-273 62.740* 66.29 Profit of 18,098 on sale
2025-04-23BUY247 61.940* 66.33
2025-04-22BUY104 61.500* 66.37
2025-04-17BUY143 59.170* 66.58
2025-04-15BUY130 60.020* 66.72
2025-04-11BUY224 56.820* 66.88
2025-04-09BUY84 59.430* 67.06
2025-04-08BUY504 55.890* 67.17
2025-04-07BUY165 59.160* 67.25
2025-04-04SELL-224 60.260* 67.32 Profit of 15,081 on sale
2025-04-02BUY1,904 68.320* 67.31
2025-04-01BUY14 67.940* 67.31
2025-03-31BUY91 70.690* 67.27
2025-03-28BUY52 71.440* 67.23
2025-03-27BUY26 72.830* 67.17
2025-03-26BUY13 71.480* 67.12
2025-03-25BUY143 71.530* 67.07
2025-03-24BUY169 71.990* 67.02
2025-03-21SELL-52 71.240* 66.97 Profit of 3,482 on sale
2025-03-20BUY208 71.600* 66.92
2025-03-19BUY39 71.320* 66.87
2025-03-18BUY468 71.520* 66.81
2025-03-17BUY91 71.550* 66.76
2025-03-14BUY676 69.440* 66.73
2025-03-13BUY130 70.600* 66.68
2025-03-12SELL-650 70.540* 66.63 Profit of 43,311 on sale
2025-03-11SELL-481 70.490* 66.58 Profit of 32,027 on sale
2025-03-10BUY143 72.030* 66.52
2025-03-07BUY26 72.230* 66.44
2025-03-05BUY195 71.190* 66.38
2025-03-04BUY221 70.510* 66.33
2025-03-03BUY416 71.020* 66.27
2025-02-28BUY338 71.160* 66.20
2025-02-27SELL-70 69.120* 66.16 Profit of 4,631 on sale
2025-02-25BUY518 71.170* 66.06
2025-02-21BUY56 68.250* 65.98
2025-02-18SELL-126 64.860* 65.96 Profit of 8,311 on sale
2025-02-14SELL-793 64.850* 66.00 Profit of 52,337 on sale
2025-02-13BUY13 64.420* 66.02
2025-02-12BUY136 65.860* 66.03
2025-02-07SELL-18 63.930* 66.14 Profit of 1,191 on sale
2025-02-06BUY247 64.340* 66.17
2025-02-05BUY65 64.185* 66.21
2025-02-04BUY78 62.870* 66.27
2025-02-03BUY78 62.440* 66.34
2025-01-31BUY143 63.360* 66.39
2025-01-29SELL-14 63.460* 66.49 Profit of 931 on sale
2025-01-28SELL-126 63.250* 66.56 Profit of 8,386 on sale
2025-01-27SELL-224 61.800* 66.65 Profit of 14,929 on sale
2025-01-24BUY168 61.730* 66.75
2025-01-23BUY28 62.190* 66.84
2024-12-10BUY650 66.430* 66.85
2024-12-09BUY78 66.810* 66.85
2024-12-06SELL-195 66.740* 66.85 Profit of 13,036 on sale
2024-12-05SELL-13 66.160* 66.87 Profit of 869 on sale
2024-12-03BUY65 63.190* 66.96
2024-11-27SELL-78 65.420* 67.11 Profit of 5,235 on sale
2024-11-26BUY273 64.880* 67.17
2024-11-25BUY35 65.090* 67.23
2024-11-22SELL-26 64.260* 67.31 Profit of 1,750 on sale
2024-11-21SELL-70 63.450* 67.42 Profit of 4,719 on sale
2024-11-20SELL-28 62.560* 67.56 Profit of 1,892 on sale
2024-11-19BUY14 61.970* 67.73
2024-11-18BUY128 61.930* 67.91
2024-11-11BUY42 66.370* 68.08
2024-11-11BUY42 66.370* 68.08
2024-11-07BUY38 66.940* 68.25
2024-11-07BUY38 66.940* 68.25
2024-11-06BUY336 66.150* 68.44
2024-11-06BUY336 66.150* 68.44
2024-11-05BUY70 66.040* 68.67
2024-11-05BUY70 66.040* 68.67
2024-11-04BUY28 66.010* 68.95
2024-11-04BUY28 66.010* 68.95
2024-11-01BUY39 66.600* 69.22
2024-11-01BUY39 66.600* 69.22
2024-10-30SELL-84 66.680* 70.12 Profit of 5,890 on sale
2024-10-30SELL-84 66.680* 70.12 Profit of 5,890 on sale
2024-10-29SELL-252 69.910* 70.16 Profit of 17,681 on sale
2024-10-29SELL-252 69.910* 70.16 Profit of 17,681 on sale
2024-10-28SELL-98 70.130* 70.17 Profit of 6,877 on sale
2024-10-28SELL-98 70.130* 70.17 Profit of 6,877 on sale
2024-10-21SELL-14 70.280* 0.00
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BMRN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19410,0268,500779,51352.6%
2025-09-18309,9349,272546,27156.7%
2025-09-17792,001761,198,91966.1%
2025-09-16481,50501,174,96941.0%
2025-09-15537,10968901,19259.6%
2025-09-12559,51941804,63869.5%
2025-09-11479,992858740,03264.9%
2025-09-10670,394301865,41977.5%
2025-09-09347,7870583,41259.6%
2025-09-08440,4270726,53560.6%
2025-09-05291,8700466,53662.6%
2025-09-04516,7790829,87862.3%
2025-09-03280,8020490,76857.2%
2025-09-02312,7570686,20245.6%
2025-08-29214,12613370,04357.9%
2025-08-28251,9167439,79557.3%
2025-08-27370,3496578,90564.0%
2025-08-26289,675233549,90452.7%
2025-08-25355,827100585,45360.8%
2025-08-22357,18416556,52864.2%
2025-08-21352,5011,525524,29367.2%
2025-08-20339,77774602,58956.4%
2025-08-19220,4370499,04144.2%
2025-08-18330,939435644,69651.3%
2025-08-15498,8220931,91353.5%
2025-08-14241,4360529,66845.6%
2025-08-13719,9923501,132,11263.6%
2025-08-12217,2424606,98935.8%
2025-08-11336,9850722,60446.6%
2025-08-08574,538391,320,70843.5%
2025-08-07387,50431837,24046.3%
2025-08-06571,71843896,31463.8%
2025-08-051,685,68712,5033,542,20047.6%
2025-08-041,579,75703,686,25742.9%
2025-08-01716,52602,200,77732.6%
2025-07-31549,45938925,08459.4%
2025-07-30718,573101,234,75558.2%
2025-07-29226,72575481,37547.1%
2025-07-28243,6265412,92959.0%
2025-07-25247,29586445,58755.5%
2025-07-24380,699137586,87264.9%
2025-07-23251,7130450,21955.9%
2025-07-22387,886114638,28360.8%
2025-07-21228,3756,803346,20866.0%
2025-07-18292,003100575,02850.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.